Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Before the Bell: Bernstein Bulls; Desperate for Vytorin

By

Merck and Schering Plough are trying to prove that they were Wrong!

PrintPRINT
Morning Perspective: Bernstein Bulls

According to Bloomberg, analysts at Sanford C. Bernstein raised their forecasts for crude oil and natural gas saying that commodities are in a "secular upward trend." The analysts say crude oil will average $92.30 a barrel in 2008 up 27% from last year's forecast due to "rising marginal cost" and declining reserves per well. The firm also raised their natural gas price targets by 7% to $8.30 per million cubic feet for 2008 as well as the stock price targets for companies like XTO Energy (XTO), Andarko Petroleum (APC), and Patterson-UTI (PTEN). For another perspective, read Professor Sally Limantour's Commodity Bull Market Alive and Well.

From the Bull Pen: Bulls can play the upside in the Natural gas fund (UNG); sell-stops can be set below $45.

From the Bear Cave: Bears that believe the commodity bubble has burst can play the downside in the oil ETF (USO); buy-stops can be set above $87.80.


Desperate for Vytorin

According to Bloomberg Merck (MRK) and Schering-Plough (SGP) will have a tough time convincing doctors that their jointly marketed cholesterol drug Vytorin failed to halt the progression of artery disease. Shares of both companies plunged in January after a preliminary finding of a study, called Enhance, showed that the drug failed to outperform older drugs giving doctors little reason to use it. Almost $50 billion in market cap was slashed from SGP and MRK. Now the companies are attempting to retain the $2.8 billion in annual sales of Vytorin by discrediting the research both companies funded and helped design. A final report will be presented this Sunday but analysts remain skeptical that any results will influence practice. Read Biotech specialist Professor David Miller's column The Problem with Drug Trials.

From the Bull Pen: Bulls can look elsewhere such as the healthcare ETF (IYH); sell-stops in the near term can be set below recent lows ($61.80).

From the Bear Cave: Those bearish can play the downside in MRK. Buy-stops can be set above the 50 DMA ($46.25).


Fore more ideas, see Minyanville's Spotlight Stocks.


Quick Check Around the World

The Friday ticks get fired up as Critters find foreign markets skewed to the upside.

Asian trading closed higher with the Hang Seng +2.74%, Nikkei +1.71%, Sensex +2.22%, Taiwan +0.20% and Shanghai +4.94%.

Looking over at Europe, we see the CAC -0.37%, DAX +0.2%, FTSE +0.04%

As of 8:30 AM EST, S&P futures +6.90 points to 1336, and Nasdaq futures are higher +10.0 points to 1802.

A Look At Commodities

Commodities are lower. Crude is down -1.07 to 106.50. Gold is lower -5.10 to 943.70. Silver is lower -0.245 to 18.305, and copper is higher +2.90 to 393.25.

The dollar index is lower -0.107 to 71.62.


On the Radar

Economics

Personal Income: 0.5% vs. 0.3% cons.
Personal Spending: 0.1% vs. 0.1% cons.
PCE Deflator (y/y):3.4% vs. 3.5% cons.
PCE Core (m/m): 0.1%vs. 0.1% cons.
PCE Core (y/y): 2.0% vs. 2.1% cons.

10:00 U of Michigan Confidence: 70.0 cons.


Let's end this week on a great note. Good luck, Minyans!
No positions in stocks mentioned.

The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.

PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE